Nanocenter Offers Promising Non-Invasive Cancer Treatment

	Tweet

A team of scientists at Arkansas Nanotechnology Center at UALR (the University of Arkansas at Little Rock) has developed what promises to be a non-invasive method of eradicating cancer cells while reducing the life-threatening side effects of chemotherapy and radiation.

The new technique, described in the current issue of the journal Nanotechnology, was developed by a team led by Dr. Alexandru Biris, assistant professor of applied science and chief scientist at the Nanotechnology Center. Working in collaboration with the University of Arkansas for Medical Sciences, the team successfully killed more than 98 percent of the cervical cancer cells used in the study.

The technique introduces nano-sized cobalt particles encased in graphitic carbon layers inside the cells and thermally activates them by using radio frequency radiation. By applying low radio frequency radiation – used in some electronic or electromagnetic devices – the magnetic portion in the nanoparticles heats up the cancerous cells, destroying them. 

The procedure promises a non-invasive method of eradicating cancer cells while reducing the life-threatening side effects of chemotherapy and radiation.

The technique is described in their new research paper, Cobalt Nanoparticles Coated with Graphitic Shells as Localized Radio Frequency Absorbers for Cancer Therapy.

“We have demonstrated that using a combination of a low frequency, low power radio frequency radiation – which has a high penetration ability in human tissue – with graphitic-magnetic composite nanoparticles could prove an excellent means of raising the temperature at the cellular level above the threshold required for DNA fragmentation or protein denaturation,” Biris said. “The result is death of the cells. This technique is less invasive and possesses higher efficiency for targeting localized cells. It also has the potential to reduce the side effects associated with traditional cancer therapies.”

With approved research protocols, UAMS scientists are expanding on previous work involving use of nanostructural materials for killing tumors with lasers. Using this method, the nanomaterials are introduced through the bloodstream to be activated with radio frequency energy once they are in the tumors.

“We believe this method is extremely promising for killing cancer cells,” said Dr. Vladmir Zharov, professor and director of the Phillips Classic Laser Laboratories in the UAMS Winthrop P. Rockefeller Cancer Institute. “We are working now to move this technology toward clinical trials with the ultimate goal of achieving a safe, effective procedure that leaves a patient cancer free.”

Biris, a native of Romania who earned a Ph.D. in applied science at UALR in 2004, said the delivery of the encased nanoparticle to tumors will also be explored by binding them to cancer-specific antibodies.

By using antibodies or other nanoparticle bioconjugations – the coupling of two substances – the nanoparticles are expected to find the cancer cells even in advanced cases, including places that before now have been considered inoperable. The nanoparticles can also find undiagnosed micrometastasis, or the spread of cancer cells from the primary site with the secondary tumors too small to be detected clinically.

“This research has extended the understanding of the mechanisms that are responsible for effective nanoparticle targeting and eventually the death of cancer cells,” Zharov said.

The team’s work is helping to explain the mechanism that is responsible for the death of the cells by figuring out the localized thermal damages such as protein denaturation and DNA fragmentation associated with the process. The finding can be applied to bacteria, viruses, or other biological systems.

Members of the research team working with Biris are:
• Yang Xu, Meena Mahmood, Zhongrui Li, and Enkeleda Dervishi, Nawab Ail, and Viney Saini, all of all of the Nanotechnology Center and Department of Applied Science at UALR.
• Vladimir P. Zharov’ group: Ekaterina Galanzha and Evgeny Shashkov, the Philips Classic Laser Laboratories at UAMS.
• Steve Trigwell of ASRC Aerospace, NASA’s Electrostatic and Surface Physics Laboratory at Kennedy Space Center in Florida.
• Alexandru R. Biris and Dan Lupu of the National Institute for Research and Development of Isotopic and Molecular Technologies, Cluj Napoca, Romania.
• Dorin Boldor of Louisiana State University’s AgCenter, Biological and Agricultural Engineering Department in Baton Rouge, LA.

Source: University of Arkansas at Little Rock

RELATED STORIES:
New target for cancer therapy identified by Australian researchers   Disabling Skp2 Gene Helps Shut Down Cancer Growth   Terminal cancer patients do not receive appropriate radiation therapy   Fugitive Cancer Cells Can be Blocked by Stopping Blood Cells That Aid Them   Chemicals in Indoor Swimming Pools May Increase Cancer Risk   Oncologists are critical in managing psychiatric disorders in patients with advanced cancer   Fewer young men in Canada are being diagnosed with cancer   Exercising With Cancer   Habits explain poor women’s worse cancer outcome   Free prescriptions over cancer   Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers   American Cancer Society report details cancer prevention efforts   Lupus linked to increased cancer risk   Cancer Staging Takes Cues from Embryonic Development   Cancer rates in U.S. keep falling: American Cancer Society   No alarm on fluoride: cancer risk unproven   Computer Predicts Anti-Cancer Molecules   Researchers Study Causes of Malignancy   Studies Investigate Health Care at the End of Life   Hodgkin Disease Survivors Face Higher Risk for Stroke Later in Life   Music-based “Play” Helps Young Cancer Patients Cope   Brain cancer takes long-term toll on children

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]